MetLife Investment Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.4M | Sell |
|
|||||
|
2025
Q2 | $2.44M | Buy |
|
|||||
|
2025
Q1 | $2.73M | Sell |
|
|||||
|
2024
Q4 | $6.1M | Buy |
|
|||||
|
2024
Q3 | $7.75M | Buy |
|
|||||
|
2024
Q2 | $4.75M | Buy |
|
|||||
|
2024
Q1 | $3.69M | Buy |
|
|||||
|
2023
Q4 | $3.09M | Hold |
|
|||||
|
2023
Q3 | $2.51M | Buy |
|
|||||
|
2023
Q2 | $2.42M | Buy |
|
|||||
|
2023
Q1 | $1.41M | Hold |
|
|||||
|
2022
Q4 | $1.8M | Buy |
|
|||||
|
2022
Q3 | $661K | Hold |
|
|||||
|
2022
Q2 | $599K | Buy |
|
|||||
|
2022
Q1 | $572K | Buy |
|
|||||
|
2021
Q4 | $356K | Hold |
|
|||||
|
2021
Q3 | $379K | Hold |
|
|||||
|
2021
Q2 | $336K | Buy |
|
|||||
|
2021
Q1 | $231K | Buy |
|
|||||
|
2020
Q4 | $209K | Hold |
|
|||||
|
2020
Q3 | $388K | Buy |
|